文献速递主动脉疾病

手辅助腹腔镜手术与腔内修复治疗腹主动脉瘤的比较

Hand-assisted laparoscopic surgery versus endovascular repair in abdominal aortic aneurysm treatment.
PubMed 文献 · J Vasc Surg · 2019-02-02

这项单中心回顾性研究纳入229例非急诊腹主动脉瘤患者,其中92例接受手辅助腹腔镜手术(HALS),137例接受腔内修复(EVAR)。两组围手术期死亡率与严重并发症无显著差异,EVAR住院时间更短,HALS长期总生存更优。

要点

  • EVAR与HALS在围手术期死亡率和严重并发症上无显著差异
  • EVAR显著缩短住院时间和重症监护时间
  • HALS长期总生存优于EVAR,再干预率更低且围手术期费用更低

核心结论

  • 在临床和解剖特征相似的人群中,EVAR与HALS治疗腹主动脉瘤的早期死亡率和并发症无显著差异。
  • EVAR住院和重症监护时间更短,HALS再干预率更低且围手术期费用更低。
  • 严格的患者选择可能是两种技术成功的关键。

研究设计与样本

  • 615例(62.9%)开放手术,173例(17.7%)HALS,189例(19.3%)EVAR。
  • 最终研究队列229例,92例(40.2%)HALS,137例(69.8%)EVAR,两组临床和人口学特征均衡。

主要发现

  • 平均随访57±28个月(EVAR组50±24个月,HALS组67±29个月,范围2-110个月)。
  • 围手术期(30天)无死亡,严重并发症或再干预无统计学显著差异。
  • 主要死亡原因:癌症24例(36.9%),非AAA相关心血管原因16例(24.6%),慢性阻塞性肺疾病10例(15.4%)。

临床怎么用

  • 对于解剖和临床适合两种术式的患者,EVAR可缩短住院时间,HALS可能降低远期再干预和费用。
  • 治疗决策需结合患者选择,两种技术均需严格把握适应证。

局限性

  • 单中心回顾性设计,患者经过高度选择,结果外推需谨慎。
  • 两组随访时间不一致(EVAR组较短),可能影响长期生存比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hand-assisted laparoscopic surgery (HALS) for the treatment of abdominal aortic aneurysm (AAA) has shown promising initial results compared with traditional surgery, but its efficacy remains highly debated. The aim of this monocentric, retrospective study was to investigate differences in morbidity, mortality, and reintervention rates between endovascular aneurysm repair (EVAR) and HALS, in the medium- and long-term follow-up in a highly selected population. METHODS: We treated 977 patients consecutively for nonurgent AAA from January 2006 to December 2013; among them, 615 (62.9%) underwent open surgery, 173 (17.7%) HALS, and 189 (19.3%) EVAR. For this study, only patients treated with HALS or EVAR were considered. A subsequent selection process was carried out to identify the patients with clinical characteristics and aneurysm morphology amenable to either of these treatments. The final study cohort included 229 patients; 92 (40.2%) underwent HALS and 137 (69.8%) received EVAR. The two populations were homogeneous for clinical and demographic characteristics. RESULTS: The mean duration of follow-up was 57 ± 28 months (50 ± 24 months in the EVAR group and 67 ± 29 months in the HALS group; range, 2-110 months). No deaths and no statistically significant differences in severe complications or reinterventions were observed over the perioperative period (30 days). Length of stay was significantly shorter after EVAR, because the need for and length of stay in the intensive care unit were decreased. Three postoperative deaths (in-hospital mortality >30 days: HALS, 2.2%; EVAR, 0.7%; P = .7268) occurred owing to respiratory failure (two patients, one in each group) and multiorgan failure secondary to a bowel ischemia (one patient in the HALS group). Other deaths in the study population were not related to the procedure. In both groups, the major causes of death were cancer (24 cases [36.9%]), cardiovascular causes unrelated to AAA (16 [24.6%]), and chronic obstructive lung disease (10 [15.4%]). In the long-term follow-up period, there was a difference in the overall survival in favor of HALS when compared with EVAR (P = .011). CONCLUSIONS: This retrospective, single-center study shows that, within a population of similar clinical and anatomic characteristics, treatment of AAA with EVAR or HALS does not result in significant differences in early morbidity and mortality. EVAR presents significantly shorter hospital and intensive care unit length of stay, whereas HALS presents a lower aneurysm-related reintervention rate and lower perioperative cost. The strict patient selection in this trial, as is generally the case with AAA treatment, is likely the key to success for both of these techniques.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Berchiolli R, Tomei F, Marconi M, et al. Hand-assisted laparoscopic surgery versus endovascular repair in abdominal aortic aneurysm treatment. J Vasc Surg. 2019. PMID: 30718111. doi:10.1016/j.jvs.2018.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。